Let AI watch the worldβs key changes for you unkAI
unkAI continuously tracks the public intelligence and global changes you care about, and only alerts you when noteworthy new developments emerge. Subscribe for free by email β no repeated interruptions, no missed key changes.
Health
44 items Β· Recommended
When will the new specific drug for Alzheimer's disease receive FDA approval?
Monitor news, data, policy signals, market reactions and key milestones regarding FDA approval of new specific drugs for Alzheimer's disease, and push information summaries when substantial changes occur.
Progress of China's innovative drugs' overseas commercialization
Track the approval progress, sales revenue growth, changes in overseas revenue proportion of Chinese innovative drugs in European and American markets, as well as the implementation of BD transactions.
Global GLP-1 Drug Market Competition and Sales Changes
Follow up on approval of new indications, entry of new players, price changes, as well as trends in market penetration and sales share changes across different regions.
When will the phase III clinical data of the first AI-developed drug be released?
Follow the release timing of phase III data of the first AI-developed drug, track whether the data results are released, and monitor changes in the subsequent marketing approval rhythm.
When will the U.S. FDA approve the new drug Anforglipron?
Follow up on whether FDA's approval result has been announced, confirm whether Anforglipron can become the first once-daily GLP-1 weight loss drug, as well as changes to its launch timing and pricing arrangements.
When will Eli Lilly's new-generation GLP-1 drug be approved for launch?
Focus on Phase III clinical results, FDA approval progress, final approval outcome, launch schedule and pricing strategy announcement.
When will the clinical trial results of the UK's 50-types-of-cancer blood test be published?
Focus on the release time of the results of the UK single blood cancer detection trial involving over 140,000 participants, awaiting data on the trial's accuracy and changes to subsequent promotion plans.
Global development trends of AI-driven biomarker detection
Follow up on the application progress of AI technology in disease prediction and biomarker detection, and pay attention to accuracy improvement and changes in clinical approval.
When will the personalized gene editing clinical trials for children with rare genetic diseases be launched?
Follow up on two personalized CRISPR gene editing therapy clinical trials for children with rare genetic diseases, focusing on launch time, patient recruitment progress and safety data disclosure.
Progress of the U.S. FDA's new drug approval reform
Follow up on FDA's reform that allows new drugs to be approved with only one clinical trial, focusing on the implementation time of the rule, adjustment of application scope and changes in industry feedback.
Progress of global clinical trials of gene editing therapies
Track the clinical trial progress of personalized gene therapies for rare genetic diseases in 2026, and pay attention to data readout, review promotion and changes in approval possibilities.
Progress of AI-designed proteins entering drug pipelines
Follow up on the follow-up clinical trial promotion and drug research and development progress after Anthropic Claude Mythos model independently designed proteins entered real drug pipelines.